Bacteriophage Cocktail Therapy for Multidrug-Resistant Gram-Negative Ventilator-Associated Pneumonia

NANot yet recruitingINTERVENTIONAL
Enrollment

248

Participants

Timeline

Start Date

November 1, 2025

Primary Completion Date

May 31, 2028

Study Completion Date

May 31, 2028

Conditions
VAP - Ventilator Associated Pneumonia
Interventions
DRUG

Phage cocktail administered via nebulization

Phage cocktail administered via nebulization,BID

DRUG

Nebulized normal saline inhalation therapy

Nebulized normal saline inhalation therapy, BID

All Listed Sponsors
collaborator

Peking University Third Hospital

OTHER

collaborator

Zhengzhou Central Hospital

OTHER

collaborator

Henan Provincial People's Hospital

OTHER

collaborator

The First Affiliated Hospital of Zhengzhou University

OTHER

collaborator

The 8th medical center of chinese PLA general hospital

UNKNOWN

collaborator

The First Medical Center of Chinese PLA General Hospital

OTHER

lead

Chinese PLA General Hospital

OTHER

NCT07202234 - Bacteriophage Cocktail Therapy for Multidrug-Resistant Gram-Negative Ventilator-Associated Pneumonia | Biotech Hunter | Biotech Hunter